Telix Pharmaceuticals | TLX - Debt



Telix Pharmaceuticals reported AUD581.45M in Debt for its fiscal semester ending in December of 2024.


Debt Change Date
Cochlear AUD 246.6M 2.9M Dec/2024
CSL USD 11.96B 219M Dec/2024
Integral Diagnostics AUD 357.8M 3.7M Jun/2024
Mayne Pharma AUD 38.82M 2.24M Jun/2024
Medical Developments International AUD 2.14M 144K Dec/2024
Mesoblast 118.92M 3.08M Jun/2024
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Pacific Edge NZD 2.9M 425K Mar/2025
Paradigm Biopharmaceuticals AUD 181.4K 38.99K Dec/2024
Polynovo AUD 15.38M 49K Jun/2024
PYC Therapeutics AUD 1.21M 96.02K Dec/2024
Ramsay Health Care AUD 11.26B 317.4M Dec/2024
ResMed USD 851.81M 179.05M Jun/2025
Sonic Healthcare AUD 4.8B 282.9M Dec/2024